142 related articles for article (PubMed ID: 19180992)
1. Modulation of eosinophil survival by epinastine hydrochloride, an H1 receptor antagonist, in vitro.
Watase F; Watanabe S; Kanai K; Yamada N; Sakaue S; Asano K; Hisamitsu T; Suzaki H
In Vivo; 2008; 22(6):687-91. PubMed ID: 19180992
[TBL] [Abstract][Full Text] [Related]
2. Suppressive activity of epinastine hydrochloride on eosinophil activation in vitro.
Mochizuki Y; Furuta A; Furuya A; Kanai K; Asano K; Suzaki H
In Vivo; 2008; 22(1):13-20. PubMed ID: 18396776
[TBL] [Abstract][Full Text] [Related]
3. Effect of desloratadine on epithelial cell granulocyte-macrophage colony-stimulating factor secretion and eosinophil survival.
Mullol J; Roca-Ferrer J; Alobid I; Pujols L; Valero A; Xaubet A; Bernal-Sprekelsen M; Picado C
Clin Exp Allergy; 2006 Jan; 36(1):52-8. PubMed ID: 16393266
[TBL] [Abstract][Full Text] [Related]
4. Mast cells enhance eosinophil survival in vitro: role of TNF-alpha and granulocyte-macrophage colony-stimulating factor.
Levi-Schaffer F; Temkin V; Malamud V; Feld S; Zilberman Y
J Immunol; 1998 Jun; 160(11):5554-62. PubMed ID: 9605160
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of tumour necrosis factor alpha mediated eosinophil survival.
Temkin V; Levi-Schaffer F
Cytokine; 2001 Jul; 15(1):20-6. PubMed ID: 11509005
[TBL] [Abstract][Full Text] [Related]
6. Suppressive activity of epinastine hydrochloride on TARC production from human peripheral blood CD4+ T cells in-vitro.
Kanai K; Asano K; Hisamitsu T; Suzaki H
J Pharm Pharmacol; 2005 Aug; 57(8):1027-36. PubMed ID: 16102259
[TBL] [Abstract][Full Text] [Related]
7. Conjunctival fibroblasts enhance the survival and functional activity of peripheral blood eosinophils in vitro.
Solomon A; Shmilowich R; Shasha D; Frucht-Pery J; Pe'er J; Bonini S; Levi-Schaffer F
Invest Ophthalmol Vis Sci; 2000 Apr; 41(5):1038-44. PubMed ID: 10752939
[TBL] [Abstract][Full Text] [Related]
8. Epinastine hydrochloride antagonism against interleukin-4-mediated T cell cytokine imbalance in vitro.
Kanai K; Asano K; Watanabe S; Kyo Y; Suzaki H
Int Arch Allergy Immunol; 2006; 140(1):43-52. PubMed ID: 16534218
[TBL] [Abstract][Full Text] [Related]
9. Airway epithelial cells release eosinophil survival-promoting factors (GM-CSF) after stimulation of proteinase-activated receptor 2.
Vliagoftis H; Befus AD; Hollenberg MD; Moqbel R
J Allergy Clin Immunol; 2001 Apr; 107(4):679-85. PubMed ID: 11295658
[TBL] [Abstract][Full Text] [Related]
10. Glucocorticoids inhibit eosinophil responses to granulocyte-macrophage colony-stimulating factor.
Lamas AM; Leon OG; Schleimer RP
J Immunol; 1991 Jul; 147(1):254-9. PubMed ID: 2051022
[TBL] [Abstract][Full Text] [Related]
11. Cultured human airway smooth muscle cells stimulated by interleukin-1beta enhance eosinophil survival.
Hallsworth MP; Soh CP; Twort CH; Lee TH; Hirst SJ
Am J Respir Cell Mol Biol; 1998 Dec; 19(6):910-9. PubMed ID: 9843925
[TBL] [Abstract][Full Text] [Related]
12. [Effect of cytokines and fibroblasts on eosinophilic granulocyte survival in polyposis nasi].
Rudack C; Hauser U; Stoll W
Laryngorhinootologie; 1999 Jul; 78(7):378-81. PubMed ID: 10457519
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the role of nasal polyp and normal nasal mucosal epithelial cells on in vitro eosinophil survival. Mediation by GM-CSF and inhibition by dexamethasone.
Xaubet A; Mullol J; López E; Roca-Ferrer J; Rozman M; Carrión T; Fabra JM; Picado C
Clin Exp Allergy; 1994 Apr; 24(4):307-17. PubMed ID: 8039016
[TBL] [Abstract][Full Text] [Related]
14. Effects of topical anti-inflammatory drugs on eosinophil survival primed by epithelial cells. Additive effect of glucocorticoids and nedocromil sodium.
Mullol J; López E; Roca-Ferrer J; Xaubet A; Pujols L; Fernàndez-Morata JC; Fabra JM; Picado C
Clin Exp Allergy; 1997 Dec; 27(12):1432-41. PubMed ID: 9433939
[TBL] [Abstract][Full Text] [Related]
15. [Eosinophil activation by epithelial cells of the respiratory mucosa. Comparative study of normal mucosa and inflammatory mucosa].
Mullol J; Xaubet A; López E; Roca-Ferrer J; Carrión T; Roselló-Catafau J; Picado C
Med Clin (Barc); 1997 May; 109(1):6-11. PubMed ID: 9303983
[TBL] [Abstract][Full Text] [Related]
16. Cell cultures from bronchial subepithelial myofibroblasts enhance eosinophil survival in vitro.
Zhang S; Mohammed Q; Burbidge A; Morland CM; Roche WR
Eur Respir J; 1996 Sep; 9(9):1839-46. PubMed ID: 8880100
[TBL] [Abstract][Full Text] [Related]
17. Eosinophil activation in the tissue: synthetic steroid, budesonide, effectively inhibits the survival of eosinophils isolated from peripheral blood but not nasal polyp tissues.
Nonaka R; Nonaka M; Takanashi S; Jordana M; Dolovich J
J Clin Lab Immunol; 1999; 51(1):39-53. PubMed ID: 11424740
[TBL] [Abstract][Full Text] [Related]
18. Suppressive effects of co-stimulatory molecule expressions on mouse splenocytes by anti-allergic agents in vitro.
Ito J; Asano K; Tryka E; Kanai K; Yamamoto S; Hisamitsu T; Suzaki H
Mediators Inflamm; 2000; 9(2):69-75. PubMed ID: 10958379
[TBL] [Abstract][Full Text] [Related]
19. Glucocorticoids inhibit granulocyte-macrophage colony-stimulating factor-1 and interleukin-5 enhanced in vitro survival of human eosinophils.
Hallsworth MP; Litchfield TM; Lee TH
Immunology; 1992 Feb; 75(2):382-5. PubMed ID: 1551701
[TBL] [Abstract][Full Text] [Related]
20. Montelukast reduces eosinophilic inflammation by inhibiting both epithelial cell cytokine secretion (GM-CSF, IL-6, IL-8) and eosinophil survival.
Mullol J; Callejas FB; Méndez-Arancibia E; Fuentes M; Alobid I; Martínez-Antón A; Valero A; Picado C; Roca-Ferrer J
J Biol Regul Homeost Agents; 2010; 24(4):403-11. PubMed ID: 21122279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
